A novel HIV vaccine targeting the protease cleavage sites

HIV preferentially infects activated CD4+ T cells and mutates rapidly. The classical vaccine approach aimed to generate broad immune responses to full HIV proteins largely failed to address the potential adverse impact of increased number of activated CD4+ T cells as viral targets. Learning from nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongzhao, Omange, Robert W., Plummer, Francis A., Luo, Ma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594498/
https://www.ncbi.nlm.nih.gov/pubmed/28893268
http://dx.doi.org/10.1186/s12981-017-0174-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594498/
https://www.ncbi.nlm.nih.gov/pubmed/28893268
http://dx.doi.org/10.1186/s12981-017-0174-7

Ejemplares similares